Weekly Recap

NeurologyLive Weekly Recap

Each week on Saturday morning, the NeurologyLive^® team puts together a weekly recap that offers a quick look into some of the top headlines in neurology news that you may have missed.

FDA Approves TBI Blood Test, Causal Link Between Smoking and Subarachnoid Hemorrhage, Inconsistencies Across EEG Education

FDA Approves TBI Blood Test, Causal Link Between Smoking and Subarachnoid Hemorrhage, Inconsistencies Across EEG Education

NeurologyLive® Staff

January 23rd 2021

Neurology News Network for the week ending January 23, 2021.

Donanemab Shows Decline in Alzheimer, Pfizer DMD Study Launched, REM Not Correlated With Seizures

Donanemab Shows Decline in Alzheimer, Pfizer DMD Study Launched, REM Not Correlated With Seizures

NeurologyLive® Staff

January 16th 2021

Neurology News Network for the week ending January 16, 2021.

FDA Approves EEG System, Neurologic Diagnostic Out-Of-Pocket Costs Rising, Nerivio Safe for Adolescents With Migraine

FDA Approves EEG System, Neurologic Diagnostic Out-Of-Pocket Costs Rising, Nerivio Safe for Adolescents With Migraine

NeurologyLive® Staff

January 9th 2021

Neurology News Network for the week ending January 9, 2021.

Larger Infarct Volume Associated With Poorer Outcomes, Edavarone Shows Efficacy in ALS, DMD Treatment Demonstrates Proof-Of-Concept

Larger Infarct Volume Associated With Poorer Outcomes, Edavarone Shows Efficacy in ALS, DMD Treatment Demonstrates Proof-Of-Concept

NeurologyLive® Staff

January 2nd 2021

Neurology News Network for the week ending January 2, 2021.

CBD Transdermal Gel Reduces Seizure Frequency, nVNS Improves Migraine, EDSS Accuracy Improvised

CBD Transdermal Gel Reduces Seizure Frequency, nVNS Improves Migraine, EDSS Accuracy Improvised

NeurologyLive® Staff

December 26th 2020

Neurology News Network for the week ending December 26, 2020.

FDA Approves Shorter-Infusion Ocrelizumab, StrokeViewer Cleared by FDA, Ezogabine Demonstrates Efficacy in ALS

FDA Approves Shorter-Infusion Ocrelizumab, StrokeViewer Cleared by FDA, Ezogabine Demonstrates Efficacy in ALS

NeurologyLive® Staff

December 19th 2020

Neurology News Network for the week ending December 19, 2020.

CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures

CBD Effective Regardless of Infantile Spasm History, Fenfluramine Effective in CDD, Wristband Sensor Data May Predict Seizures

NeurologyLive® Staff

December 12th 2020

Neurology News Network for the week ending December 12, 2020.

Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation

Smartphone PMR Treats Migraine, NMOSD Relapse in Pregnant Women, FDA Grants ALS Agent Orphan Drug Designation

NeurologyLive® Staff

December 5th 2020

Neurology News Network for the week ending December 5, 2020.

NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment

NDA For INP104 Submitted, Sodium Oxybate Improves Nocturnal RBD, Health-Deficit Accumulation Leads to Cognitive Impairment

NeurologyLive® Staff

November 28th 2020

Neurology News Network for the week ending November 28, 2020.

Early Life Working Impacts Cognitive Decline, Cleveland Clinic Awarded NIH Grant, Earlier Treatment More Effective in Parkinson Disease

Early Life Working Impacts Cognitive Decline, Cleveland Clinic Awarded NIH Grant, Earlier Treatment More Effective in Parkinson Disease

NeurologyLive® Staff

November 21st 2020

Neurology News Network for the week ending November 21, 2020.

Aducanumab Not Recommended by FDA, White Paper on Mechanical Thrombectomy, Status Epilepticus Treatment FDA Approved

Aducanumab Not Recommended by FDA, White Paper on Mechanical Thrombectomy, Status Epilepticus Treatment FDA Approved

NeurologyLive® Staff

November 14th 2020

Neurology News Network for the week ending November 14, 2020.

PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published

PD GENEration Receives Additional Funding, Continuous Ocrelizumab Effective in Progressive MS, Guidelines for Down Syndrome Published

NeurologyLive® Staff

November 7th 2020

Neurology News Network for the week ending November 7, 2020.

Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission

Diazepam Granted Fast Track, Nerivio Receives FDA Clearance, Zolmitriptan Gets CRL Following NDA Submission

NeurologyLive® Staff

October 31st 2020

Neurology News Network for the week ending October 31, 2020.

JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit

JZP-258 Effective to Treat Narcolepsy, Pavel Klein Discusses Telemedicine Limitations, Earlier Focal Epilepsy Diagnosis Shows Benefit

NeurologyLive® Staff

October 24th 2020

Neurology News Network for the week ending October 24, 2020.

sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation

sNDA Accepted For Rimegepant, FDA Expands Pitolisant Indication, Givinostat Wins Rare Pediatric Disease Designation

NeurologyLive® Staff

October 17th 2020

Neurology News Network for the week ending October 17, 2020.

Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan

Zolgensma Shows Therapeutic Benefit, Anticholinergic Medications Increase MCI Risk, FDA Issues DRL For Zolmitriptan

NeurologyLive® Staff

October 10th 2020

Neurology News Network for the week ending October 10, 2020.

FDA Sends CRL For Diazepam, Insomnia Linked to Cognitive Impairment, Midazolam Underutilized By EMS

FDA Sends CRL For Diazepam, Insomnia Linked to Cognitive Impairment, Midazolam Underutilized By EMS

NeurologyLive® Staff

October 3rd 2020

Neurology News Network for the week ending October 2, 2020.

Sumifilam Improves Alzheimer Biomarkers, Fenfluramine Phase 3 Results, Ozanimod Lowers ARR

Sumifilam Improves Alzheimer Biomarkers, Fenfluramine Phase 3 Results, Ozanimod Lowers ARR

NeurologyLive® Staff

September 26th 2020

Neurology News Network for the week ending September 26, 2020.

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

Opicapone Treats Motor Fluctuations, Directional DBS Favored in PD, MRgFUS is Effective as Hand Tremor Treatment

NeurologyLive® Staff

September 19th 2020

Neurology News Network for the week ending September 19, 2020.

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

Pocket Card Treats Status Epilepticus, Pitolisant Shows No Cardiac Signals, SSRIs Associated With Increased Risk of Recurrent Stroke

NeurologyLive® Staff

September 12th 2020

Neurology News Network for the week ending September 12, 2020.

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

NeurologyLive® Staff

September 5th 2020

Neurology News Network for the week ending September 5, 2020.

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

NeurologyLive® Staff

Neurology News Network for the week ending May 9, 2020.

Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine

Risdiplam Meets End Point, Fenfluramine Effective in Treating Dravet Syndrome, Rimegepant Sees Early Results in Migraine

NeurologyLive® Staff

Neurology News Network for the week ending May 2.

Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine

Daridorexant Improves Daytime Sleepiness, Vutrisiran Gains Fast Track Designation, Erenumab Effective in Migraine

NeurologyLive® Staff

April 25th 2020

Neurology News Network for the week ending April 25, 2020.

Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab

Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab

NeurologyLive® Staff

April 18th 2020

Neurology News Network for the week ending April 18, 2020.

Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS

Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS

NeurologyLive® Staff

April 11th 2020

Neurology News Network for the week ending April 11, 2020.

CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease

CBD Under FDA Review, Rimegepant Meets Endpoint, Sleep-Disordered Breathing Associated With Alzheimer Disease

NeurologyLive® Staff

Neurology News Network for the week ending April 4, 2020.

Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast

Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast

NeurologyLive® Staff

March 21st 2020

Neurology News Network for the week ending March 21, 2020.

Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update

Cenobamate Gets Schedule V Designation, ICER Publishes Migraine Treatment Review, FDA Approves RNS System Labeling Update

NeurologyLive® Staff

March 14th 2020

Neurology News Network for the week ending March 14, 2020.

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

NeurologyLive® Staff

Neurology News Network for the week ending March 7, 2020.

...

4 5 6 7 8 9 10 >

Latest News

A Clinician’s Perspective on First-in-Human Data for LRRK2 Degrader ARV-102

A Clinician’s Perspective on First-in-Human Data for LRRK2 Degrader ARV-102

Lisette Kogelman, MSc (Credit: LinkedIn)

Large Danish Cohort Study Reveals No Significant Association Between HLA Alleles and Migraine

Ditte Primdahl, MD; Shailee Samir Shah, MD

Recognizing and Managing Paraneoplastic Neurological Syndromes: Ditte Primdahl, MD; Shailee Samir Shah, MD

Afterimage Duration Significantly Longer in Migraine With Aura Than Without

Afterimage Duration Significantly Longer in Migraine With Aura Than Without

Do Not Sell My Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

© 2025 MJH Life Sciences

All rights reserved.